Investing
Paige says the new funds will be used to continue the growth of its platform by creating diagnostic and clinical improvements to patient care.
Also: Truepill to expand digital pharmacy business with $25 million Series B; Nucleai's precision oncology platform gains $6.5 million from Debiopharm.
Like its competitors, the telehealth provider highlighted a major increase in business since COVID-19.
Telehealth and digital behavioral health were two of the most popular investment areas.
Despite the uncertainty of COVID-19, funding deals during the last three months were generally on par with those of Q1 2020 and Q2 2019.
Also: NexHealth's $15 million Series A, Avive Solutions' $7 million raise and Cyclica's $16.9 million Series B.
This latest contribution was led by Mubadala Capital and Bpifrance.
Alphabet, General Catalyst, Kholsa Ventures, Lakestar, Thrive Capital and Baillie Gifford participated in this round.